Silexion Therapeutics Ltd. (SLXN)

NASDAQ·Healthcare·Biotechnology

$3.09

+0.00%

Mkt Cap $1.10M

No analyst coverage available

We don't have analyst ratings or price target data for Silexion Therapeutics Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.